Managing the daily realities of COPD often falls on patients who lack the clinical expertise to navigate complex treatment options and insurance hurdles. The new initiative pairs patients with Lung Health Navigators—registered nurses and respiratory therapists—to offer personalized support via phone, video, or live chat. These experts guide participants through medication adherence, lifestyle adjustments, and the process of seeking second opinions, effectively extending care beyond the physician’s office.

The clinical impact of this support is measurable. Participants in the program reported a decrease in symptom severity, with an average reduction of 2.9 points on the COPD Assessment Test. Beyond direct patient support, the campaign is expanding its reach into high-risk regions, including Alabama, Florida, and Kentucky, where Medicare hospitalization rates for the disease remain disproportionately high. The initiative also introduces educational resources for patients transitioning home after hospital exacerbations and a diagnostic questionnaire designed to combat high rates of undiagnosed cases. Supported by partners including Sanofi and AstraZeneca, the program provides a critical safety net for those struggling to control a condition that carries an average annual medical cost of $16,000 per patient.